The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis

Rheumatology International

Volumn 32, Issue 1, 2012, Pages 199-206

  Oelzner, Peter ^a   Franke, Sybille ^a   Lehmann, Gabriele ^a   Eidner, Thorsten ^a   Hein, Gert ^a   Wolf, Gunter ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Bone mineral density; RANKL OPG ratio; Rheumatoid arthritis; Soluble gp130; Soluble IL 6 receptor

Indexed keywords

C REACTIVE PROTEIN; DEOXYPYRIDINOLINE; GLUCOCORTICOID; GLYCOPROTEIN; GLYCOPROTEIN 130; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PREDNISOLONE; PYRIDINOLINE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOLYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BONE DENSITY; CYTOKINE RECEPTOR GP130; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-6; LINEAR MODELS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; RANK LIGAND; RECEPTORS, INTERLEUKIN-6; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84857120627     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1606-z     Document Type: Article

References (49)

1. YY Kong U Feige I Sarosi B Bolon A Tafuri S Morony C Capparelli J Li R Elliott S McCabe T Wong G Campagnuolo E Moran ER Bogoch G Van LT Nguyen PS Ohashi DL Lacey E Fish WJ Boyle JM Penninger 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 304 309 10580503 10.1038/46303 1:CAS:528:DyaK1MXnvFShsLg%3D (Pubitemid 129516268)
2. EM Gravallese C Manning A Tsay A Naito C Pan E Amento SR Goldring 2000 Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor Arthritis Rheum 43 250 258 10693863 10.1002/1529- 0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P 1:STN:280:DC%2BD3c7lsFGgsg%3D%3D (Pubitemid 30395732)
3. H Takayanagi H Iizuka T Juji T Nakagawa A Yamamoto T Miyazaki Y Koshihara H Oda K Nakamura S Tanaka 2000 Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis Arthritis Rheum 43 259 269 10693864 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W 1:CAS:528:DC%2BD3cXhs1aqtLw%3D (Pubitemid 30395733)
4. G Schett K Redlich S Hayer J Zwerina B Bolon C Dunstan B Gortz A Schulz H Bergmeister G Kollias G Steiner JS Smolen 2003 Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice Arthritis Rheum 48 2042 2051 12847699 10.1002/art.11150 1:CAS:528:DC%2BD3sXmtFartbY%3D (Pubitemid 36828700)
5. M Stolina S Adamu M Ominsky D Dwyer F Asuncion Z Geng S Middleton H Brown J Pretorius G Schett B Bolon U Feige D Zack PJ Kostenuik 2005 RANKL is the marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis J Bone Miner Res 20 1756 1765 16160733 10.1359/JBMR.050601 1:CAS:528:DC%2BD2MXhtFGrtLnP (Pubitemid 41361876)
6. D Diarra M Stolina K Polzer J Zwerina MS Ominsky D Dwyer A Korb S Smolen M Hoffmann C Scheinecker D van der Heide R Landewe D Lacey WG Richards G Schett 2007 Dickkopf-1 is a master regulator of joint remodeling Nat Med 13 156 163 17237793 10.1038/nm1538 1:CAS:528:DC%2BD2sXhsVyktbY%3D
7. LC Hofbauer DL Lacey CR Dunstan TC Spelsberg BL Riggs S Khosla 1999 Interleukin-1beta and tumor necrosis factor alpha, but not interleukin-6 stimulate osteoprotegerin ligand gene expression in human osteolastic cells Bone 25 255 259 10495128 10.1016/S8756-3282(99)00162-3 1:CAS:528:DyaK1MXls1Wiu78%3D (Pubitemid 29406050)
8. S Theoleyre Y Wittrant SK Tat Y Fortun F Redini D Heymann 2004 The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling Cytokine Growth Factor Rev 15 457 475 15561602 10.1016/j.cytogfr.2004.06.004 1:CAS:528:DC%2BD2cXhtVSlurbI (Pubitemid 39550455)
9. S Kwan Tat M Padrines S Theolyre D Heymann Y Fortun 2004 IL-6, RANKL, TNF-alpha/IL-1: interrelation in bone resorption pathophysiology Cytokine Growth Factor Rev 15 49 60 14746813 10.1016/j.cytogfr.2003.10.005 (Pubitemid 38121290)
10. LC Hofbauer F Gori BL Riggs DL Lacey CR Dunstan TC Spelsberg S Khosla 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis Endocrinology 140 4382 4389 10499489 10.1210/en.140.10.4382 1:CAS:528:DyaK1MXmtFGrurw%3D (Pubitemid 30666099)
11. P Oelzner A Müller F Deschner M Hüller K Abendroth G Hein G Stein 1998 Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis Calcif Tissue Int 62 193 198 9501950 10.1007/s002239900416 1:CAS:528:DyaK1cXhsFylsrs%3D (Pubitemid 28127929)
12. T Sugiyama 2001 Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis J Bone Miner Res 19 89 96 10.1007/s007740170046 1:CAS:528:DC%2BD3MXktlektL8%3D (Pubitemid 32290704)
13. C Scheidt-Nave H Bismar G Leidig-Bruckner H Woitge M Seibel R Ziegler J Pfeilschifter 2001 Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause J Endocrinol Metab 86 2032 2042 10.1210/jc.86.5.2032 1:CAS:528:DC%2BD3MXjs1Omtr0%3D (Pubitemid 32472916)
14. N Giuliani P Sansoni G Girasole R Vescovini G Passeri M Passeri M Pedrazzoni 2001 Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes Exp Gerontol 36 547 557 11250125 10.1016/S0531-5565(00)00220-5 1:CAS:528: DC%2BD3MXhslyru74%3D (Pubitemid 32201509)
15. S Rose-John J Scheller G Elson SA Jones 2006 Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer J Leukoc Biol 80 227 236 16707558 10.1189/jlb.1105674 1:CAS:528:DC%2BD28Xot1Ons7c%3D (Pubitemid 44835496)
16. J Scheller S Rose-John 2006 Interleukin-6 and its receptor: from bench to bedside Med Microbiol Immunol 195 173 183 16741736 10.1007/s00430-006-0019-9 1:CAS:528:DC%2BD28XhtVyktL3I (Pubitemid 44600378)
17. PJ Richards MA Nowell S Horiuchi RM McLoughlin CA Fielding S Grau N Yamamoto M Ehrmann S Rose-John AS Williams SA Jones 2006 Functional characterization of a soluble gp130 isofrom and its therapeutic capacity in an experimental model of inflammatory arthritis Arthritis Rheum 54 1662 1672 16646038 10.1002/art.21818 1:CAS:528:DC%2BD28XlsFWjs78%3D
18. MA Nowell AS Williams SA Carty J Scheller AJ Hayes GW Jones PJ Richards S Slinn M Ernst BJ Jenkins N Topley S Rose-John SA Jones 2009 Therapeutic targeting of IL-6 trans-signaling counteracts STAT3 control of experimental inflammatory arthritis J Immunol 182 613 622 19109195 1:CAS:528: DC%2BD1cXhsFCisL3P
19. FC Arnett SM Edworthy DA Bloch 1988 The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis Arthritis Rheum 31 315 324 3358796 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D (Pubitemid 18091653)
20. U Lange U Müller-Ladner 2007 Glucocorticoid-induced osteoporosis Z Rheumatol 66 129 136 17334736 10.1007/s00393-007-0151-y 1:CAS:528: DC%2BD2sXlsVWqs7c%3D (Pubitemid 46472531)
21. A Müller G Hein S Franke D Herrmann S Henzgen A Roth G Stein 1996 Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography Rheumatol Int 16 23 28 8783419 10.1007/BF01419951 (Pubitemid 26168684)
22. Einspruch EL (ed) (2005) An introductory guide to SPSS for windows. Sage, Thousand Oaks, London, New Delhi
23. C Ding V Parameswaran R Udayan J Burgess G Jones 2008 Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study J Clin Endocrinol Metab 93 1952 1958 18285417 10.1210/jc.2007-2325 1:CAS:528:DC%2BD1cXlvFWgtrc%3D (Pubitemid 351656543)
24. SL Ferrrari L Ahn-Luong P Garnero SE Humphries SL Greenspan 2003 Two promotor polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of c-reactive protein and markers of bone resorption in postmenopausal women J Endocrinol Metab 88 255 259 10.1210/jc.2002-020092 (Pubitemid 36115175)
25. SK Tat JP Pelletier D Lajeuinesse H Fahmi N Duval J Martel-Pelletier 2008 Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors Bone 43 284 291 18539107 10.1016/j.bone.2008.04.006 1:CAS:528:DC%2BD1cXosVOit7o%3D
26. T Nakashima Y Kobayashi S Yamasaki A Kawakami K Eguchi H Sasaki H Sakai 2000 Protein expression and functional difference of membrane-bound and soluble receptor activator of NFkappaB ligand: modulation of the expression by osteotropic factors and cytokines Biochem Biophys Res Commun 275 768 775 10973797 10.1006/bbrc.2000.3379 1:CAS:528:DC%2BD3cXmtFGlsL8%3D
27. P Palmqvist E Persson HH Conaway UH Lerner 2002 IL-6, leukaemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae J Immunol 169 3353 3362 12218157 1:CAS:528:DC%2BD38XntFags70%3D (Pubitemid 35013185)
28. NA Sims BJ Jenkins JM Quinn A Nakamura M Glatt MT Gillespie M Ernst TJ Martin 2004 Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways J Clin Invest 113 379 389 14755335 1:CAS:528:DC%2BD2cXhtFSls7w%3D (Pubitemid 38544182)
29. NA Sims 2009 Gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice Mol Cell Endocrinol 310 30 39 18805458 10.1016/j.mce.2008.08.025 1:CAS:528:DC%2BD1MXhtVKlsr%2FE
30. V Poli R Balena E Fattori A Markatos M Yamamoto H Tanaka G Ciliberto GA Roadan F Costantini 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion EMBO J 13 1189 1196 8131749 1:CAS:528:DyaK2cXitFGjt74%3D (Pubitemid 24074725)
31. M Hayashi MC Rho A Enomoto A Fukami YP Kim Y Kikuchi T Sunazaka T Hirose K Komiyama S Omura 2002 Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130 Proc Natl Acad Sci USA 99 14728 14733 12417753 10.1073/pnas.232562799 1:CAS:528:DC%2BD38Xpt1yrsb0%3D (Pubitemid 35334552)
32. HI Shin P Divieti NA Sims T Kobayashi D Miao A Karapalis R Baron R Bringhurst HM Kronenberg 2004 Gp130-mediated signalling is necessary for normal osteoblastic function in vivo and in vitro Endocrinology 145 1376 1385 14617570 10.1210/en.2003-0839 1:CAS:528:DC%2BD2cXhs1Wit7o%3D (Pubitemid 38281022)
33. A Grey MA Mitnick U Masiukiewicz BH Sun S Rudikoff RL Jilka SC Manolagas K Insogna 1999 A role of interleukin-6 in parathyroid hormone-induced bone resorption in vivo Endocrinology 140 4683 4690 10499526 10.1210/en.140.10.4683 1:CAS:528:DyaK1MXmtFGqs7c%3D (Pubitemid 30666136)
34. PK Wong JM Quinn NA Sims A van Nieuwenhuijze IK Campbell IP Wicks 2006 Interleukin-6 modulates production of T-lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis Arthritis Rheum 54 158 168 16385511 10.1002/art.21537 1:CAS:528: DC%2BD28XhsVensL0%3D (Pubitemid 43122198)
35. C Vermes JJ Jacobs J Zhang G Firneisz KA Roebuck TT Glant 2002 Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts J Biol Chem 277 16879 16887 11884403 10.1074/jbc.M200546200 1:CAS:528:DC%2BD38XjslWhtb0%3D (Pubitemid 34967713)
36. T Tamura N Udagawa N Takahashi C Miyaura S Tanaka Y Yamada Y Koishihara Y Ohsugi K Kumaki T Taga, et al. 1993 Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6 Proc Natl Acad Sci USA 90 11924 11928 8265649 10.1073/pnas.90.24.11924 1:CAS:528:DyaK2cXnsFWksA%3D%3D (Pubitemid 24008752)
37. S Kotake K Sato KJ Kim N Takahashi N Udagawa I Nakamura A Yamaguchi T Kishimoto T Suda S Kashiwazaki 1996 Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation J Bone Miner Res 11 88 95 8770701 10.1002/jbmr.5650110113 1:CAS:528:DyaK28Xht1Gnurw%3D (Pubitemid 26026748)
38. XH Liu SA Kirschenbaum S Yao AC Levine 2005 Crosstalk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-(kappa)B (RANK) ligand/RANK system Endocrinology 146 1991 1998 15618359 10.1210/en.2004-1167 1:CAS:528:DC%2BD2MXis1yqurY%3D (Pubitemid 40396909)
39. XH Liu A Kirschenbaum S Yao AC Levine 2006 Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system Ann Acad Sci 1068 225 233 10.1196/annals.1346.047 1:CAS:528: DC%2BD28XntFentbc%3D (Pubitemid 43824153)
40. C Sanchez O Gabay C Salvat YE Henrotin F Berenbaum 2009 Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts Osteoarthr Cartil 17 473 481 18974013 10.1016/j.joca.2008.09.007 1:STN:280:DC%2BD1M3gtlWktw%3D%3D
41. G Mossetti D Rendina G De Filippo R Viceconti G Di Domenico M Cioffi L Postiglione V Nunziata 2005 Interleukin-6 and osteoprotegerin systems in Paget's disease of bone: relationship to risedronate treatment Bone 36 540 554 10.1016/j.bone.2004.11.004 (Pubitemid 40403853)
42. H Tsangari DM Findlay JS Kuliwaba GJ Atkins NL Fazzalari 2004 Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck Bone 35 334 342 15207775 10.1016/j.bone.2004.02.006 1:CAS:528:DC%2BD2cXltVGjsLs%3D (Pubitemid 38789182)
43. IA Nakchbandi R Lang B Kinder KL Insogna 2008 The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism J Clin Endocrinol Metab 93 967 973 18073309 10.1210/jc.2007-1645 1:CAS:528:DC%2BD1cXjsFymsr0%3D (Pubitemid 351398581)
44. K Insogna M Mitnick J Pascarella I Nakchbandi A Grey U Masiukiewicz 2002 Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women J Bone Miner Res 17 Suppl 2 N108 N116 12412787 1:CAS:528:DC%2BD38XoslemsLc%3D
45. A Angeli A Dovio ML Sartori RG Masera B Ceoloni P Prolo S Racca F Chiappelli 2002 Interactions between glucocorticoids and cytokines in the bone microenvironment Ann NY Acad Sci 966 97 107 12114264 10.1111/j.1749-6632.2002. tb04207.x 1:CAS:528:DC%2BD38XlvVWmtr0%3D (Pubitemid 34729166)
46. A Polgar M Brozik S Toth M Holub A Falus 2002 A synthetic corticosteroid, dexamethasone regulates generation of soluble form of interleukin-6 receptor of human lymphocytes, in vitro Acta Biol Hung 53 307 315 12371610 10.1556/ABiol.53.2002.3.7 1:CAS:528:DC%2BD3sXis1Ghtbo%3D (Pubitemid 34961454)
47. K Murakami-Mori S Mori T Taga T Kishimoto S Nakamura 1997 Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation J Immunol 158 5518 5526 9164976 1:CAS:528:DyaK2sXjtl2qs7g%3D (Pubitemid 127681262)
48. T Takeda H Kurachi T Yamamoto Y Nishio Y Nakatsuji K-i Morishige A Miyake Y Murata 1998 Crosstalk between the interleukin-(IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid J Endocrinol 159 323 330 9795374 10.1677/joe.0.1590323 1:CAS:528:DyaK1cXnsVyrs74%3D (Pubitemid 28520186)
49. A Dovio L Perazzolo L Saba A Termine M Capobianco A Bertolotto A Angeli 2006 High dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption Eur J Endocrinol 154 745 751 16645023 10.1530/eje.1.02147 1:CAS:528:DC%2BD28XltV2jsbg%3D (Pubitemid 43810862)